Zynex Acquires Kestrel Labs

December 22, 2021

Zynex, Inc. acquired 100% of Kestrel Labs, Inc. in a transaction that closed December 22, 2021 for approximately $31.0 million (about $16.0 million cash financed by Bank of America and $15.0 million in Zynex common stock). Kestrel Labs develops laser-based, noninvasive patient monitoring devices (NiCO CO‑Oximeter and HemeOx) that are not yet FDA-cleared; Zynex said it will integrate the technologies into its monitoring portfolio and pursue regulatory clearance and commercialization.

Buyers
Zynex, Inc.
Targets
Kestrel Labs, Inc.
Industry
Medical Devices
Location
Colorado, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.